Astroglial alterations in amyotrophic lateral sclerosis (ALS) model of slow glutamate excitotoxicity in vitro

Folia Neuropathologica

Volumn 44, Issue 3, 2006, Pages 183-190

  Matyja, Ewa ^a   Taraszewska, Anna ^a   Nagańska, Ewa ^a   Rafałowska, Janina ^a   Gebarowska, Jolanta ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Astroglial changes; Chronic excitotoxicity; Glutamate uptake blockers; Rat spinal cord in vitro

Indexed keywords

2,4 PYRROLIDINEDICARBOXYLIC ACID; ASPARTIC ACID DERIVATIVE; GLUTAMIC ACID; THREOHYDROASPARTATE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; EXCITOTOXICITY; IN VITRO STUDY; LUMBAR SPINAL CORD; NERVE CELL DEGENERATION; NONHUMAN; PATHOGENESIS; RAT; SMOOTH ENDOPLASMIC RETICULUM;

EID: 33750323461     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Anneser JM, Cookson MR, Ince PG, Shaw PJ, Borasio GD. Glial cells of the spiral cord and subcortical white matter upregulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis. Exp Neurol 2001; 171: 418-421.
2. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999; 22: 208-215.
3. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JS. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 2004; 47: 263-274.
4. Bezzi P, Volterra A. A neuro-glia signalling network in the active brain Curr Opin Neurobiol 2001; 11: 387-394.
5. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338.
6. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-634.
7. Danbolt NC, Chaudhry FA, Dehnes Y, Lehre KP, Levy LM, Ullensvang K, Storm-Mathisen J. Properties and localization of glutamate transporters. Prog Brain Res 1998; 116: 23-43.
8. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001; 36: 180-190.
9. Fray AE, Ince PG, Banner SJ, Milton ID, Usher PA, Cookson MR, Shaw PJ. Tne expression of the glial glutamate transporter protein EAAT2 a motor neuron disease: an immunohistochemical study. Eur J Neurosci 1998; 10: 2481-2489.
10. Furuta A, Rothstein JD, Martin L. Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci 1997; 17: 8363-8375.
11. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775. Erratum in: Science 1995; 269: 149.
12. Grieb P. Transgenic models of amyotrophic lateral sclerosis. Folia Neuropathol 2004; 42: 239-248.
13. Hansson E. Metabotropic glutamate receptor activation induces astroglial swelling. J Biol Chem 1994; 269: 21955-21961
14. Hansson E, Ronnback L. Astrocytes in glutamate neurotransmission. FASEB J 1995; 9: 343-350.
15. Hansson E, Muyderman H, Leonova J, Allansson L, Sinclair J, Blomstrand F, Thorlin T, Nilsson M, Ronnback L. Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochem Int 2000; 37: 317-329.
16. Hirano A. Neuropathology of ALS: an overview. Neurology 1996; 47: S63-S66.
17. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 2002; 99: 1604-1609.
18. Kushner PD, Stephenson DT, Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 1991; 50: 263-277.
19. Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 1995; 15: 1835-1853.
20. Levine JB, Kong J, Nadler M, Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 1999; 28: 215-224.
21. Maihofner C, Probst-Cousin S, Bergmann M, Neuhuber W, Neundorfer B, Heuss D. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur J Neurosci 2003; 18: 1527-1534.
22. Matyja F, Nagańska F, Taraszewska A, Rafałowska J. The mode of spinal motor neurons degeneration in a model of slow glutamate excitotoxicity in vitro. Folia Neuropathol 2005; 43: 7-13.
23. Matyja E, Taraszewska A, Naganska E, Rafalowska J. Autophagic degeneration of motor neurons in a model of slow glutamate excitotoxicity in vitro. Ultrastruct Pathol 2005; 29: 331-339.
24. Nagy D, Kato T, Kushner PD. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J Neurosci Res 1994; 38: 336-347.
25. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 1994; 263: 1768-1771.
26. Norenberg MD. Astrocyte response to CNS injury. J Neuropathol Exp Neurol 1994; 53: 213-220.
27. Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. Glutamate-mediated astrocyte-neuron signalling. Nature 1994; 369: 744-747.
28. Raghavendra Rao VL, Baskaya MK, Muralikrishna Rao A, Dogan A, Dempsey RJ. Increased ornithine decarboxylase activity and protein level in the cortex following traumatic brain injury in rats. Brain Res 1998; 783: 163-166.
29. Rao SD, Yin HZ, Weiss JH. Disrupton of glial glutamate transport by reactve oxygen species produced in motor neurons. J Neurosci 2003; 23: 2627-2633.
30. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997; 20: 570-577.
31. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326: 1464-1468.
32. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci U S A 1993; 90: 6591-6595.
33. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW. Localizaton of neuronal and glial glutamate transporters. Neuron 1994; 13: 713-725.
34. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
35. Rothstein JD. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 1995; 68: 7-20.
36. Rothstein JD. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci 1995; 96: 348-359.
37. Salinska E, Danysz W, Lazarewicz JW. The role of excitotoxicity in neurodegeneration. Folia Neuropathol 2005; 43: 322-339.
38. Sasaki S, Komori T, Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 2000; 100: 138-144.
39. Schiffer D, Cordera S, Cavalla P, Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J Neurobiol Sci 1996; 139: 27-33.
40. Schipper HM. Astrocytes, brain aging, and neurodegeneration. Neurobiol Aging 1966; 17: 467-480.
41. Shahani N, Nalini A, Gourie-Devi M, Raju TR. Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients witn amyotrophic lateral sclerosis. Exp Neurol 1998; 149: 295-298.
42. Shashidharan P, Plaitakis A. Cloning and characterization of a glutamate transporter cDNA from human cerebellum. Biochim Biophys Acta 1993; 1216: 161-164.
43. Shashidharan P, Huntley GW, Meyer T, Morrison JH, Plaitakis A. Neuron-specific human glutamate transporter: molecular cloning, characterization and expression in human brain. Brain Res 1994; 662: 245-250.
44. Shaw PJ, Forrest V, Ince PG, Richardson JP, Wastell HJ. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neuredegeneration 1995; 4: 209-216.
45. Silani V, Braga M, Ciammola A, Cardin V, Scarlato G. Motor neurones in culture as a model to study ALS. J Neurol 2000; 247 (suppl 1): 128-36.
46. Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, La Forestier N, Marouan A, Dib M, Meininger V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 2002; 193: 73-78.
47. Steinhauser C, Gallo V. News on glutamate receptors in glial cells. Trends Neurosci 1996; 19: 339-345.
48. Storck T, Schulte S, Hofmann K, Stoffel W. Structure, expression, one functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci U S A 1992; 89: 10955-10959.
49. Tacconi MT. Neuronal death: is there a role for astrocytes? Neurochem Res 1998; 23: 759-765.
50. Takahashi M, Billups B, Rossi D, Sarantis M, Hamann M, Attwell D. The role of glutamate transporters in glutamate homeostasis in the brain. J Exp Biol 1997; 200: 401-409.
51. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K. Epilepsy one exacerbation of brain injury in mice lacking tne glutamate transporter GLT-1. Science 1997; 276: 1699-1702.
52. Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 1998; 19: 328-334.
53. Trotti D, Rolfs A, Danbolt NC, Brown RH Jr, Hediger MA. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 1999; 2: 427-433. Erratum in: Nat Neurosci 1999; 2: 848.
54. Vanoni C, Massari S, Losa M, Carrega P, Perego C, Conforti L, Pietrini G. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell moeel for familial amyotrophic lateral sclerosis (ALS). J Cell Sci 2004; 117: 5417-5426.